Relation of daily urinary hormone patterns to vasomotor symptoms in a racially/ethnically diverse sample of midlife women: Study of women's health across the nation

Reproductive Sciences

Volumn 14, Issue 8, 2007, Pages 786-797

  Gold, Ellen B ^a,b   Lasley, Bill ^b   Crawford, Sybil L ^c   McConnell, Dan ^d   Joffe, Hadine ^e   Greendale, Gail A ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Body weight; Endogenous hormones; Hot flashes; Menopause; Ovarian function; Race ethnicity; Smoking; Socioeconomic status

Indexed keywords

ESTROGEN; FOLLITROPIN; LUTEINIZING HORMONE; PREGNANEDIOL; PREGNANEDIOL GLUCURONIDE; GLUCURONIDE;

ADULT; ARTICLE; CLIMACTERIUM; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HORMONE URINE LEVEL; HUMAN; MAJOR CLINICAL STUDY; MENSTRUATION; OBESITY; OVULATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SYMPTOMATOLOGY; VASOMOTOR DISORDER; WOMEN'S HEALTH; CLINICAL TRIAL; COHORT ANALYSIS; HOT FLUSH; LONGITUDINAL STUDY; MENSTRUAL CYCLE; MIDDLE AGED; MULTICENTER STUDY; UNITED STATES; URINE;

COHORT STUDIES; FEMALE; FOLLICLE STIMULATING HORMONE; GLUCURONIDES; HOT FLASHES; HUMANS; LONGITUDINAL STUDIES; LUTEINIZING HORMONE; MENSTRUAL CYCLE; MIDDLE AGED; PERIMENOPAUSE; PREGNANEDIOL; UNITED STATES; WOMEN'S HEALTH;

EID: 39049084440     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719107308613     Document Type: Article

References (42)

1. Hutton JD, Jacobs HS, Murray MAF, James VHT. Relation between plasma oestrone and oestradiol and climacteric symptoms. Lancet. 1978 ; 1: 671-681.
2. Askel S., Schomberg DW, Tyrey L., Hammond CB Vasomotor symptoms, serum estrogens, and gonadotropin levels in surgical menopause. Am J Obstet Gynecol. 1976 ; 126: 165-169.
3. Matthews KA, Wing RR, Kuller LH, Meilahn EN, Plantinga P. Influence of the peri-menopause on cardiovascular risk factors and symptoms of middle-aged healthy women. Arch Intern Med. 1994 ; 154: 2349-2355.
4. Dennerstein L., Dudley EC, Hopper JL, et al. A prospective population-based study of menopausal symptoms. Obstet Gynecol. 2000 ; 96: 351-358.
5. Guthrie JR, Dennerstein L., Hopper JL, Burger HG Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women. Obstet Gynecol. 1996 ; 88: 437-442.
6. Freedman RR, Woodward S. Core body temperature during menopausal hot flushes. Fertil Steril. 1996 ; 65: 1141-1144.
7. Randolph JF Jr, Sowers MF, Bondarenko I., et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms across the menopausal transition. J Clin Endocrinol Metab. 2005 ; 90: 6106-6112.
8. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002 ; 288: 321-333.
9. Santoro N., Crawford SL, Allsworth JE, et al. Assessing comparative features of menstrual cycles using urinary hormone assays. Am J Physiol Endocrinol Metab. 2003 ; 284: E521 - E530.
10. Gold EB, Block G., Crawford S., et al. Lifestyle, demographic and hormonal factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation (SWAN). Am J Epidemiol. 2004 ; 159: 1189-1199.
11. Gold EB, Colvin A., Avis N., et al. Longitudinal analysis of vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women's Health Across the Nation (SWAN). Am J Public Health. 2006 ; 96: 1226-1235.
12. Sowers MF, Crawford S., Morgenstein D., et al. Design and methods of SWAN: a multi-center, multi-ethnic, communitybased cohort study of midlife women. In: Lobo R, Marcus R, Kelsey J, eds. Menopause. San Diego, CA: Academic Press ; 2000: 170-181.
13. Livesey JH, Roud HK, Metcalf MG, Donald RA Glycerol prevents loss of immunoreactive follicle-stimulating hormone and luteinizing hormone from frozen urine. J Endocrinol. 1983 ; 98: 381-384.
14. Saketo M., Sharma N., Adel T., Raguwanshi M., Santoro N. Utility of time resolved fluorescent immunoassay techniques for urinary gonadotropin measurement. Clin Chem. 1994 ; 40: 749-753.
15. Santoro N., Brown JR, Adel T., Skurnick JH Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab. 1996 ; 81: 1495-1501.
16. Taussky HH A microcolorimetric determination of creatinine in urine by the Jaffe reaction. J Biol Chem. 1954 ; 208: 835-861.
17. Waller K., Swan SH, Windham GC, Fenster L., Elkin EP, Lasley BL Use of urine biomarkers to evaluate menstrual function in healthy premenopausal women. Am J Epidemiol. 1998 ; 147: 1071-1080.
18. Santoro N., Lasley B., McConnell D., et al. Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: the Study of Women's Health Across the Nation (SWAN) Daily Hormone Study. J Clin Endocrinol Metab. 2004 ; 89: 2622-2631.
19. Kassam A., DeSouza MJ, Overstreet JW, Gold EB, Snow-Harter C., Lasley BL Identification of anovulation and transient luteal function using a urinary pregnanediol-3-glucuronide ratio algorithm. Environ Health Perspect. 1996 ; 104: 408-413.
20. Burger HG, Robertson DM, Baksheev L., Collins A., Csemiczky G., Landgren B-M. The relationship between the endocrine characteristics and the regularity of menstrual cycles in the approach to menopause. Menopause. 2005 ; 2: 267-274.
21. Metcalf MG, Donald RA, Livesey JH Classification of menstrual cycles in pre- and perimenopausal women. J Endocrinol. 1981 ; 91: 1-10.
22. Deziegler D., Bergeron C., Bouchard P., Frydman R. Controlled preparation of the endometrium with exogenous estradiol and progesterone in women having functional ovaries. Fertil Steril. 1991 ; 56: 851-855.
23. Hollander M., Wolfe DA Nonparametric Statistical Methods. 2 nd ed. New York, NY: John Wiley & Sons ; 1999.
24. Ferris BG Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis. 1978 ; 118: 1-120.
25. Sternfeld B., Ainsworth BA, Quesenberry CP Jr. Physical activity patterns in a diverse population of women. Prev Med. 1999 ; 28: 313-323.
26. Baecke JAH, Burema J., Fritjers JER. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982 ; 36: 936-942.
27. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity. Geneva, Switzerland: World Health Organization ; 1998.
28. Barsky AJ, Goodson JD, Lane RS, Cleary PD The amplification of somatic symptoms. Psychosom Med. 1988 ; 50: 510-519.
29. Agresti A. Analysis of Ordinal Categorical Data. New York, NY: John Wiley & Sons ; 1984.
30. McEwen BS, Alves SE Estrogen actions in the central nervous system. Endocr Rev. 1999 ; 20: 279-307.
31. Stephenson LA, Kolka MA Esophageal temperature threshold for sweating decreases before ovulation in premenopausal women. J Appl Physiol. 1999 ; 86: 22-28.
32. Freedman RR, Subramanian M. Effects of symptomatic status and the menstrual cycle on hot flash-related thermoregulatory parameters. Menopause. 2005 ; 12: 156-159.
33. Sternfeld B., Quesenberry CP Jr, Husson G. Habitual physical activity and menopausal symptoms: a case-control study. J Womens Health. 1999 ; 8: 115-123.
34. Ford K., Sowers MF, Crutchfield M., Wilson A., Jannausch M. A longitudinal study of the predictors of prevalence and severity of symptoms commonly associated with menopause. Menopause. 2005 ; 12: 308-317.
35. Dennerstein L., Smith AMA, Morse CA, et al. Menopausal symptoms in Australian women. Med J Aust. 1993 ; 159: 232-236.
36. Schwingl PJ, Hulka BS, Harlow SD Risk factors for menopausal hot flashes. Obstet Gynecol. 1994 ; 84: 29-34.
37. Starpoli CA, Flaws JA, Bush TL, Mouton AW Predictors of menopausal hot flashes. J Womens Health. 1998 ; 7: 1149-1155.
38. Wilbur J., Miller AM, Montgomery A., Chandler P. Sociodemographic characteristics, biological factors, and symptom reporting in midlife women. Menopause. 1998 ; 5: 43-51.
39. Freeman EW, Sammel MD, Grisso JA, Battistini M., Garcia-Espagna B., Hollander L. Hot flashes in the late reproductive years: risk factors for African American and Caucasian women. J Womens Health Gend Based Med. 2001 ; 10: 67-76.
40. Hankinson SE, Willett WC, Manson JE, et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst. 1995 ; 87: 1297-1302.
41. Cauley JA, Gutal JP, Kuller LH, DeDonne D., Powell JG The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol. 1989 ; 129: 1120-1131.
42. Freedman RR, Blacker CM Estrogen raises the sweating threshold in postmenopausal women with hot flashes. Fertil Steril. 2002 ; 77: 487-490.